Richard H. Myers

The paper quantifies transposable element RNA dynamics in aging human and mouse brains and neurodegenerative diseases, finding age-related changes and disease-specific TE RNA dysregulation.

The paper identifies genetic modifiers of somatic CAG expansion and clinical phenotypes in Huntington's disease, revealing shared and tissue-specific effects on disease timing and pathogenic processes.

The paper identifies a shared genetic risk module involving PSEN2 and actin regulation across alpha-synucleinopathies, linking them to Alzheimer's disease mechanisms.

The paper identifies differentially expressed mRNAs and microRNAs in human brain tissues associated with obesity and BMI using RNA sequencing from multiple cohorts.

This study identifies genetic modifiers of LRRK2 mutations in Parkinson's disease, finding a significant variant in CORO1C and a polygenic risk score effect on penetrance.

The paper investigates genetic risk factors for psychiatric and cognitive symptoms in Huntington’s Disease using polygenic risk scores and finds associations between specific psychiatric risk scores and corresponding symptoms.

This study compares gene expression in asymptomatic Huntington’s disease carriers' caudate nucleus with symptomatic HD and healthy controls, identifying unique transcriptional changes in early stages of the disease.

This study shows that the length of uninterrupted CAG repeats, not the encoded polyglutamine segment, determines Huntington's disease onset, and DNA maintenance genes modify this process.

This study identifies over 50 new genetic loci associated with pulmonary function through a multiethnic meta-analysis of 90,715 individuals.

This study compares mRNA-Seq data from Huntington and Parkinson Diseases to identify common and unique transcriptional signatures, revealing shared inflammatory processes and differential biological pathway enrichments.